Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Total Non-Current Liabilities: 2024

Historic Total Non-Current Liabilities for Kura Oncology (KURA) over the last 1 years, with Dec 2024 value amounting to $344.7 million.

  • Kura Oncology's Total Non-Current Liabilities rose 653.54% to $403.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $403.9 million, marking a year-over-year increase of 653.54%. This contributed to the annual value of $344.7 million for FY2024, which is N/A change from last year.
  • Per Kura Oncology's latest filing, its Total Non-Current Liabilities stood at $344.7 million for FY2024.
  • Kura Oncology's Total Non-Current Liabilities' 5-year high stood at $344.7 million during FY2024, with a 5-year trough of $344.7 million in FY2024.
  • Moreover, its 1-year median value for Total Non-Current Liabilities was $344.7 million (2024), whereas its average is $344.7 million.